Wyeth, Teva Say Effexor Pay-For-Delay Suit Fell Short
Wyeth and Teva said Tuesday that the Third Circuit should not revive antitrust claims over an alleged bribe to delay a generic version of the antidepressant Effexor XR, arguing that the...To view the full article, register now.
Already a subscriber? Click here to view full article